Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity.

Clinton W Enos,Vanessa L Ramos,Robert R McLean,Tin-Chi Lin,Nicole Foster,Blessing Dube,Abby S Van Voorhees

The Journal of dermatological treatment（2022）

引用 1|浏览15

暂无评分

摘要

Multimorbidity in psoriasis may decrease the likelihood of achieving treatment response to biologic therapy and should be considered when discussing treatment expectations with patients.

查看译文

关键词

Psoriasis,biologic therapy,biologics,comorbid disease,metabolic disease,multimorbidity,outcomes,psoriatic disease,treatment response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要